GlaxoSmithKline

مادة اعلانية

Latest Update: 21 Jan 2025 16:28 Abu Dhabi Time.

Market Status: Closed

BIOC

GlaxoSmithKline

40.80

EGP

2.800

7.37%

Open

38.00

Prev Close

40.80

PX_VOLUME

383,069

MARKET CAP (M)

DAY RANGE

38.00 - 41.41

52 WEEKS

24.70 - 47.50

Stock Statistics

Yearly Change

9.80%

Listed Shares (Million)

83.51

Earnings Multiple

28.50

Average 30-day trading volume

72,660.38

Price-to-book ratio

1.77

Earnings Per Share

0.72

Previous Dividend Distribution

Dividend Yield

1.84%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		787.08	642.45	713.81	663.47	576.44
Gross Profit		175.96	330.14	326.35	459.45	170.45
Operating Income		81.65	132.86	76.32	291.41	105.17
Profit Margin		1.69	15.81	-1.26	2.07	4.71

	Period Ending:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		2,240.22	1,817.67	1,014.99	1,992.83
Gross Profit		843.33	572.53	307.04	779.84
Operating Income		440.90	18.94	11.49	202.51
Profit Margin		2.70	-6.26	-6.74	1.41

Balance Sheet

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		3,712.12	3,744.61	3,971.75	3,557.92	3,557.41
Total Liabilities		1,784.72	1,830.48	2,089.49	1,592.59	1,605.81
Total Equity		1,927.40	1,914.13	1,882.26	1,965.33	1,951.60

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.